CLINICAL_TRIALS
trial_result
· 2015-01-14
Clinical Trial Update: Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia [Phase 3]
Summary
A Phase 3 trial evaluating risk-adapted combination chemotherapy in young patients with acute lymphoblastic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Associazione Italiana Ematologia Oncologia Pediatrica | Conditions: Leukemia | Phase 3 | Status: COMPLETED